Assess whether the carve-out is operable on day one (fa53de)

SITUATION A public acquirer facing HSR and sector regulators cannot treat a founder who will not sign a non-compete as incidental context on QoE add-backs the seller marked 'normalized'. Commercial-diligence partner must close the carve-out is operable from that extract under M&A Due Diligence / Separation and Integration.

DECISION Commercial-diligence partner in a public acquirer facing HSR and sector regulators must choose Proceed / Reprice / Walk / Hold using QoE add-backs the seller marked 'normalized' after a founder who will not sign a non-compete.

HYPOTHESES TO TEST 1. Authorize Proceed now; QoE add-backs the seller marked 'normalized' already has the discriminator after a founder who will not sign a non-compete. 2. Keep Reprice in force until QoE add-backs the seller marked 'normalized' is completed after a founder who will not sign a non-compete for commercial-diligence partner. 3. Treat QoE add-backs the seller marked 'normalized' as Walk because both readings appear after a founder who will not sign a non-compete. 4. Refuse a M&A Due Diligence close: commercial-diligence partner does not have the decision the carve-out is operable turns on in QoE add-backs the seller marked 'normalized'.

ANALYSIS REQUIRED 1. Map reps, earnout mechanics, and integration risk a public acquirer facing HSR and sector regulators would inherit. 2. Tie quality-of-earnings, working-capital, and contingent items in QoE add-backs the seller marked 'normalized' to the carve-out is operable. 3. Name the document commercial-diligence partner still needs before signing. 4. For this M&A Due Diligence Separation and Integration file, read QoE add-backs the seller marked 'normalized' against a founder who will not sign a non-compete and write the one fact that would move the carve-out is operable for commercial-diligence partner.

RECOMMENDATION Choose Proceed / Reprice / Walk / Hold on this M&A Due Diligence / Separation and Integration packet (QoE add-backs the seller marked 'normalized' after a founder who will not sign a non-compete). Lead with the M&A Due Diligence option QoE add-backs the seller marked 'normalized' can support after a founder who will not sign a non-compete, then the two facts that force it, then the Monday action for commercial-diligence partner in a public acquirer facing HSR and sector regulators.

COMMAND RETURNS - Bottom-line M&A Due Diligence option on the carve-out is operable, then the evidence in QoE add-backs the seller marked 'normalized', then the action for commercial-diligence partner - Hypothesis scorecard against QoE add-backs the seller marked 'normalized': supported / rejected / untestable - Separation and Integration finding in QoE add-backs the seller marked 'normalized' that a second reviewer can re-perform - Missing page in QoE add-backs the seller marked 'normalized' after a founder who will not sign a non-compete, if any